1Shirasaka T, Shimamoto Y, Ohshima H, et al. Development of a novel form of an oral 5-fluorouracil derivative ( S- 1 ) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators [ J ]. Anticancer Drugs, 1996, 7 : 548.
2Takeharu Y, Shigemi M, Satoshi T, et al. Safety evaluation of oral fluoropyrimidine S-1 for short-and long-term delivery in advanced gastric cancer: Analysis of 3 758 patients [J]. Cancer Chemother Pharmaeol, 2008, 61:335.
3Koizumi W, Kurihara M, Nakano S, et al. Phase Ⅱ study of S-1 , a novel oral derivative of 5-fluorouracil, in advanced gastric cancer [J]. Oncology, 2000, 58 : 191.
4Sakata Y, Ohtsu A, Horikoshi N, et al. Late Phase Ⅱ study of novel oral fluoropyrimidine anticancer drug S-1 ( 1M tegafur-0. 4M otastat potassium) in advanced gastric cancer patients [J]. EUR J Cancer, 1998, 34 : 1715.
5Koizumi W, Tanabe S, Saigenji K, et al. Phase Ⅰ/Ⅱ study of S-1 combined with cisplatin in patients with advanced gastric [J]. Br J Cancer, 2003, 8:2207.
6Ajani JA, Lee FC, Singh DA, et al. Multicenter phase Ⅱ trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma [J]. J Clin Oncol, 2006, 24 : 663.
7Jae-Lyun L, Hye JK, Yoon-Kook, et al. Phase Ⅰ/Ⅱ study of 3-week combination of S-1 and Cisplatin chemotherapy for metastatic or recurrent gastric cancer [ J ]. Cancer Chemother Pharmacol, 2008, 61 : 837.
8Inokuchi M, Yamashita T, Yamada H, et al. Phase Ⅰ/Ⅱ study of S-1 combined with irinotecan for metastatic advanced gastric cancer [J]. Br J Cancer, 2006, 94 : 1130.
9Yamaguchi K, Shimamura T, Hyodo I, et al. Phase Ⅰ/Ⅱ study of docetaxel and S-1 in patients with advanced gastric cancer [J]. Br J Cancer, 2006, 94:1803.
10Mochiki E, Ohno T, amiyama Y, et al. Phase Ⅰ/Ⅱ study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer [ J ]. Br J Cancer, 2006, 95 : 1642.
10Sakata Y,Ohtsu A,Horikoshi N,et al. Late phase I1 study of novel oral fluoropyrimidine anticancer drug S-1 ( 1 M tegafur-0.4 M gimestat-1 M 0tastat potassium) in advanced gastric cancer patients [J]. Eur J Cancer, 1998,34( 11 ) :1715-1720.
